Literature DB >> 30180238

Intravitreal Methotrexate for Iris and Ciliary Body Relapse in Acute Lymphoblastic Leukemia.

Luiz Guilherme M Mello, Patrícia de Paula Effgen, Kélcia Kiefer.   

Abstract

The authors report a rare unilateral iris and ciliary body relapse in acute lymphoblastic leukemia. Ophthalmologic examination showed reduced visual acuity, pseudohypopyon, and iris irregularity. Ultrasound biomicroscopy and aqueous humor cytology confirmed leukemic infiltration. Lesions were treated with intravitreal methotrexate, which has not been described previously for acute lymphoblastic leukemia. [J Pediatr Ophthalmol Strabismus. 2018;55:e16-e19.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30180238     DOI： 10.3928/01913913-20180608-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN： 0191-3913            Impact factor:   1.402


  3 in total

Review 1.  A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.

Authors:  Nasiq Hasan; Rohan Chawla; Nawazish Shaikh; Sindhuja Kandasamy; Shorya Vardhan Azad; M Dheepak Sundar
Journal:  Ther Adv Ophthalmol       Date:  2022-05-18

2.  Ocular Manifestations of Leukemia and Results of Treatment with Intravitreal Methotrexate.

Authors:  Vicktoria Vishnevskia-Dai; Sara Sella King; Ruth Lekach; Ido Didi Fabian; Ofira Zloto
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

3.  Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia.

Authors:  Matteo Pederzolli; Fabio Giglio; Maria Vittoria Cicinelli; Alessandro Marchese; Giulio Modorati; Sara Mastaglio; Fabio Ciceri; Francesco Bandello; Elisabetta Miserocchi
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.